ArticleTrials2022

Tolvaptan versus fluid restriction in acutely hospitalised patients with moderate-profound hyponatraemia (TVFR-HypoNa): design and implementation of an open-label randomised trial.

Annabelle M Warren et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.